Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy

NCT06941870 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Factor VIII Deficiency

Interventions

DRUG: Efanesoctocog alfa

Sponsor

Sanofi